News

CLINICAL relapse risk amongst individuals with ulcerative colitis (UC) more common if the levels of vitamin D in the blood are lower than required…

A POTENTIAL link has been discerned between gut bacteria and behaviour in patients with irritable bowel syndrome (IBS), a common gastrointestinal…

This March, EMJ has proudly showcased its support for an assortment of medical campaigns including: Ovarian Cancer Awareness Month, World Kidney Day…

Krakow, Poland / Berlin, Germany, March 28, 2017 – Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today…

FOCUSSED ultrasound has been suggested as a future therapy for the gentler treatment of tumours of the liver. Already used readily as a diagnostic method…

LIVER cells have been found to have their own ability to burn accumulated fat, according to Swedish researchers. A new clinical trial has been planned…

PEMBROLIZUMAB, a highly selective, humanised monoclonal antibody targeting programmed cell death 1 (PD-1), has a superior safety profile and improved…

RESULTS published from a Phase II clinical trial have shown the potential of the investigational drug savolitinib in the treatment of c-MET-driven…